PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Clinical Medicine, University of Cambridge School of Clinical Medicine, Cambridge, UK.\', \'Nuffield Department of Medicine, Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.\', \'Department of Microbiology and Infectious Diseases, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.\', \'Department of Zoology, University of Oxford, Oxford, UK jose.lourenco@zoo.ox.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e00427510.1136/bmjgh-2020-004275
?:hasPublicationType
?:journal
  • BMJ global health
is ?:pmid of
?:pmid
?:pmid
  • 33402334
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all